Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 50 | 0 | 5 | 0 | €705.70 | €766.92 | 8.674% |
| Biogen Inc. | 45 | 1 | 5 | 1 | €205.70 | €294.01 | 42.932% |
| Vertex Pharmaceuticals Inc. | 45 | 2 | 7 | 0 | €392.60 | €406.87 | 3.634% |
| Alnylam Pharmace. | 36 | 0 | 3 | 0 | €139.65 | €236.30 | 69.207% |
| Regeneron Pharmaceuticals Inc. | 34 | 1 | 5 | 1 | €903.60 | €957.22 | 5.934% |
| Johnson & Johnson | 32 | 1 | 3 | 0 | €139.16 | €196.74 | 41.374% |
| Neurocrine Bioscience | 28 | 0 | 7 | 0 | €126.90 | €140.34 | 10.591% |
| Merck & Co. Inc. | 28 | 1 | 1 | 0 | €120.80 | €124.93 | 3.418% |
| Pfizer Inc. | 31 | 4 | 3 | 0 | €26.01 | €41.10 | 58.028% |
| Cytokinetics Inc. | 27 | 1 | 3 | 0 | €58.00 | €85.64 | 47.661% |
| Amgen Inc. | 25 | 0 | 6 | 0 | €287.90 | €297.31 | 3.269% |
| Intra-Cellular Therapies Inc. | 24 | 0 | 7 | 0 | €60.50 | €79.55 | 31.495% |
| Zoetis Inc. A | 23 | 1 | 5 | 0 | €156.94 | €200.06 | 27.474% |
| AbbVie Inc. | 21 | 0 | 4 | 0 | €149.20 | €174.43 | 16.913% |